Results 191 to 200 of about 56,109 (361)

Hydrocarbon Potential of Aleutian Basin, Bering Sea: ABSTRACT

, 1980
David W. Scholl Alan K. Cooper
openalex   +1 more source

Isolated Mast Cell–Mediated Angioedema: Clinically Different but Endotypically Similar to Chronic Spontaneous Urticaria

Clinical &Experimental Allergy, EarlyView.
Thomas Buttgereit, Claudia Hayford, Carolina Vera Ayala, Sherezade Moñino‐Romero, Yi‐Kui Xiang, Pavel Kolkhir, Carolin Steinert, Denise Freier, Markus Magerl, Jörg Scheffel, Karsten Weller   +10 more
wiley   +1 more source

ENSO's changing grip on Bering Sea ice: The emerging control of the North Pacific meridional mode. [PDF]

Sci Adv
Chen J, Yu JY, Wang C, Liu J, Wang X, Chen S, Zhang L, He Z.   +7 more
europepmc   +1 more source

Diurnal Variations in Salmon Catch by Surface Gillnets in the Bering Sea During the Summer.

, 1991
Teruo Azuma
openalex   +2 more sources

Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo‐Controlled, Double‐Blind, Crossover Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Oxytocin is expressed throughout the small intestine, suggesting a role for oxytocin in postprandial metabolism. Accordingly, single‐dose intranasal oxytocin reduces food intake and improves glucose tolerance. We investigated the effects of a continuous intravenous oxytocin infusion on ad libitum food intake, appetite sensations ...
Ida M. Gether, Vivian Kliim‐Hansen, Petur T. Olafsson, Miriam G. Pedersen, Casper K. Nielsen, Anne‐Marie Ellegaard, Mikkel B. Christensen, Jens F. Rehfeld, Jørn W. Helge, Jens J. Holst, Bolette Hartmann, Filip K. Knop, Lærke S. Gasbjerg, Asger B. Lund   +13 more
wiley   +1 more source

Saxitoxin linked to deaths of northern fur seals in the Southeast Bering Sea. [PDF]

Mar Mamm Sci
Lefebvre KA, Campbell CM, Divine LM, Melovidov P, Hellen H, Huntington KB, Bowers EK, Rouse N, Fachon E, Farrugia TJ, Pickart RS, Lin P, Lago L, Bahr F, Furst E, Duncan CG, Charapata P, Anderson DM, Kurtay G.   +18 more
europepmc   +1 more source

Efficacy and Safety of Prophylaxis With a Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease—A WIL‐31 Study Sub‐Analysis

European Journal of Haematology, EarlyView.
ABSTRACT Objectives The WIL‐31 study demonstrated efficacy and safety of prophylaxis with the plasma‐derived von Willebrand factor/factor VIII concentrate wilate in von Willebrand disease (VWD) of all types and was the only prospective study with an on‐demand run‐in study as an intra‐individual comparator.
Claudia Djambas Khayat, Leonid Dubey, Adlette Inati, Toshko Lissitchkov, Dzmitry Novik, Elina Peteva, Robert F. Sidonio Jr, Ali T. Taher, Kateryna V. Vilchevska, Vladimir Vdovin, Ana Boban   +10 more
wiley   +1 more source

Developing the Petroleum Resources of Bering Sea--Technology, Economics, and Geology: ABSTRACT

, 1982
William W. Wade Peter T. Hanley
openalex   +1 more source

Completion of the Icatibant Outcome Survey and What We Learned

Clinical &Experimental Allergy, EarlyView.
Laurence Bouillet, Werner Aberer, Teresa Caballero, Anete S. Grumach, Hilary J. Longhurst, Alissa Dangel, Natalie Khutoryansky, Irmgard Andresen, Andrea Zanichelli   +8 more
wiley   +1 more source

Cost‐Effectiveness of Venetoclax‐Based Treatment in Treatment‐Naïve Fit Patients With CLL Without TP53 Aberrations

European Journal of Haematology, EarlyView.
ABSTRACT The GAIA‐CLL13 trial showed that venetoclax‐obinutuzumab (Ven‐O) based regimens, with or without ibrutinib, offer superior efficacy compared to chemoimmunotherapy (CIT) with regards to progression free survival (PFS) in fit, treatment‐naïve (TN) CLL patients. However, their higher costs warrant a cost‐effectiveness evaluation.
Lars Holger Ehlers, Mark‐David Levin, Marjolein van der Klift, Morten Berg Jensen, Hoa Thi Tuyet Tran, Arnon P. Kater, Carsten Utoft Niemann   +6 more
wiley   +1 more source